Analysis reveals clinical prognosis for steroid-induced osteonecrosis in children with immune kidney disease, indicating treatment concerns.
Background Glucocorticoid (GC) is the first-line treatment for immune kidney diseases; long-term or excessive use of GC can lead to steroid-induced osteonecrosis of the femoral head (SONFH). We analysed the clinical prognosis and associated factors of SONFH in children with immune kidney disease treated with GC.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: